Expression of ERCC1, p53, and Class III β-Tubulin Do Not Reveal Chemoresistance in Endometrial Cancer: Results From an Immunohistochemical Study
Ingrid Vandenput, An Capoen, Lieve Coenegrachts, Godelieve Verbist, Philippe Moerman, Ignace Vergote, Frédéric Amant
International Journal of Gynecologic Cancer Aug 2011, 21 (6) 1071-1077; DOI: 10.1097/IGC.0b013e318218f28b